PTG-100, an Oral α4β7 Antagonist Peptide: Preclinical Development and Phase 1 and 2a Studies in Ulcerative Colitis

202136 citationsJournal Articlebronze Open Access

Authors

Good health and well-being

Published in: Gastroenterology

Volume 161, Issue 6, pp. 1853-1864.e10

Field-Weighted Citation Impact: 4.86